In this study, we analyzed the genomic and clinical data on four female cancers (BRCA, OV, UCEC, and CESC) from the TCGA Pan-Cancer Atlas [26] to better understand the correlation of ER expression, ER pathway activation, and alternative pathway activation in patients with these cancers. Here, ESR1 is linked to cancer.